These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35782147)

  • 21. Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens.
    Williams AR; Douglas AD; Miura K; Illingworth JJ; Choudhary P; Murungi LM; Furze JM; Diouf A; Miotto O; Crosnier C; Wright GJ; Kwiatkowski DP; Fairhurst RM; Long CA; Draper SJ
    PLoS Pathog; 2012; 8(11):e1002991. PubMed ID: 23144611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural basis for inhibition of erythrocyte invasion by antibodies to
    Chen L; Xu Y; Wong W; Thompson JK; Healer J; Goddard-Borger ED; Lawrence MC; Cowman AF
    Elife; 2017 Feb; 6():. PubMed ID: 28195530
    [No Abstract]   [Full Text] [Related]  

  • 23. RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting.
    Healer J; Thompson JK; Mackwell KL; Browne CD; Seager BA; Ngo A; Lowes KN; Silk SE; Pulido D; King LDW; Christen JM; Noe AR; Kotraiah V; Masendycz PJ; Rajagopalan R; Lucas L; Stanford MM; Soisson L; Diggs C; Miller R; Youll S; Wycherley K; Draper SJ; Cowman AF
    Front Cell Infect Microbiol; 2022; 12():1049065. PubMed ID: 36605129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional Comparison of Blood-Stage
    Illingworth JJ; Alanine DG; Brown R; Marshall JM; Bartlett HE; Silk SE; Labbé GM; Quinkert D; Cho JS; Wendler JP; Pattinson DJ; Barfod L; Douglas AD; Shea MW; Wright KE; de Cassan SC; Higgins MK; Draper SJ
    Front Immunol; 2019; 10():1254. PubMed ID: 31214195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of a Genetically Modified Chimeric
    Miyazaki Y; Marin-Mogollon C; Imai T; Mendes AM; van der Laak R; Sturm A; Geurten FJA; Miyazaki S; Chevalley-Maurel S; Ramesar J; Kolli SK; Kroeze H; van Schuijlenburg R; Salman AM; Wilder BK; Reyes-Sandoval A; Dechering KJ; Prudêncio M; Janse CJ; Khan SM; Franke-Fayard B
    Front Cell Infect Microbiol; 2020; 10():591046. PubMed ID: 33392104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A complex equation - adding to Plasmodium falciparum invasion.
    Björnsson KH; Barfod L
    Trends Parasitol; 2023 Mar; 39(3):160-162. PubMed ID: 36682939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Divergent roles for the RH5 complex components, CyRPA and RIPR in human-infective malaria parasites.
    Knuepfer E; Wright KE; Kumar Prajapati S; Rawlinson TA; Mohring F; Koch M; Lyth OR; Howell SA; Villasis E; Snijders AP; Moon RW; Draper SJ; Rosanas-Urgell A; Higgins MK; Baum J; Holder AA
    PLoS Pathog; 2019 Jun; 15(6):e1007809. PubMed ID: 31185066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A highly infectious Plasmodium yoelii parasite, bearing Plasmodium falciparum circumsporozoite protein.
    Zhang M; Kaneko I; Tsao T; Mitchell R; Nardin EH; Iwanaga S; Yuda M; Tsuji M
    Malar J; 2016 Apr; 15():201. PubMed ID: 27068454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5.
    Douglas AD; Williams AR; Knuepfer E; Illingworth JJ; Furze JM; Crosnier C; Choudhary P; Bustamante LY; Zakutansky SE; Awuah DK; Alanine DG; Theron M; Worth A; Shimkets R; Rayner JC; Holder AA; Wright GJ; Draper SJ
    J Immunol; 2014 Jan; 192(1):245-58. PubMed ID: 24293631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The essential malaria protein PfCyRPA targets glycans to invade erythrocytes.
    Day CJ; Favuzza P; Bielfeld S; Haselhorst T; Seefeldt L; Hauser J; Shewell LK; Flueck C; Poole J; Jen FE; Schäfer A; Dangy JP; Gilberger TW; França CT; Duraisingh MT; Tamborrini M; Brancucci NMB; Grüring C; Filarsky M; Jennings MP; Pluschke G
    Cell Rep; 2024 Apr; 43(4):114012. PubMed ID: 38573856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Editorial: The First Monoclonal Antibody Vaccine to Prevent Malaria Heralds a New Era of Malaria Vaccines to the Plasmodium falciparum Circumsporozoite Protein (PfCSP).
    Parums DV
    Med Sci Monit; 2021 Sep; 27():e934676. PubMed ID: 34511592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythrocyte invasion-neutralising antibodies prevent
    Jamwal A; Constantin CF; Hirschi S; Henrich S; Bildl W; Fakler B; Draper SJ; Schulte U; Higgins MK
    Elife; 2023 Oct; 12():. PubMed ID: 37796723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies.
    Alanine DGW; Quinkert D; Kumarasingha R; Mehmood S; Donnellan FR; Minkah NK; Dadonaite B; Diouf A; Galaway F; Silk SE; Jamwal A; Marshall JM; Miura K; Foquet L; Elias SC; Labbé GM; Douglas AD; Jin J; Payne RO; Illingworth JJ; Pattinson DJ; Pulido D; Williams BG; de Jongh WA; Wright GJ; Kappe SHI; Robinson CV; Long CA; Crabb BS; Gilson PR; Higgins MK; Draper SJ
    Cell; 2019 Jun; 178(1):216-228.e21. PubMed ID: 31204103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics of antibody responses to PfRH5-complex antigens in Ghanaian children with Plasmodium falciparum malaria.
    Partey FD; Castberg FC; Sarbah EW; Silk SE; Awandare GA; Draper SJ; Opoku N; Kweku M; Ofori MF; Hviid L; Barfod L
    PLoS One; 2018; 13(6):e0198371. PubMed ID: 29883485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody Combinations Targeting the Essential Antigens CyRPA, RH5, and MSP-119 Potently Neutralize Plasmodium falciparum Clinical Isolates From India and Africa.
    Singh H; Mian SY; Pandey AK; Krishna S; Anand G; Reddy KS; Chaturvedi N; Bahl V; Hans N; Shukla MM; Bassat Q; Mayor A; Miura K; Bharti PK; Long C; Singh N; Chauhan VS; Gaur D
    J Infect Dis; 2021 Jun; 223(11):1953-1964. PubMed ID: 32989463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinations.
    Azasi Y; Gallagher SK; Diouf A; Dabbs RA; Jin J; Mian SY; Narum DL; Long CA; Gaur D; Draper SJ; Fay MP; Miller LH; Miura K
    Sci Rep; 2020 Jul; 10(1):11802. PubMed ID: 32678144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of precision in growth inhibition assay (GIA) using human anti-PfRH5 antibodies.
    Miura K; Diouf A; Fay MP; Barrett JR; Payne RO; Olotu AI; Minassian AM; Silk SE; Draper SJ; Long CA
    Malar J; 2023 May; 22(1):159. PubMed ID: 37208733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmodium falciparum merozoite surface antigen, PfRH5, elicits detectable levels of invasion-inhibiting antibodies in humans.
    Patel SD; Ahouidi AD; Bei AK; Dieye TN; Mboup S; Harrison SC; Duraisingh MT
    J Infect Dis; 2013 Nov; 208(10):1679-87. PubMed ID: 23904294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination with virosomally formulated recombinant CyRPA elicits protective antibodies against
    Tamborrini M; Hauser J; Schäfer A; Amacker M; Favuzza P; Kyungtak K; Fleury S; Pluschke G
    NPJ Vaccines; 2020; 5():9. PubMed ID: 32025340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strain-transcending neutralization of malaria parasite by antibodies against Plasmodium falciparum enolase.
    Dutta S; Tewari A; Balaji C; Verma R; Moitra A; Yadav M; Agrawal P; Sahal D; Jarori GK
    Malar J; 2018 Aug; 17(1):304. PubMed ID: 30126436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.